Key points are not available for this paper at this time.
// Tamás Barbai 1 , Zsuzsanna Fejős 1 , Laszlo G. Puskas 2 , József Tímár 1,3 and Erzsébet Rásó 1,3 1 2nd Department of Pathology, Semmelweis University, Budapest, Hungary 2 Avidin Ltd., Szeged, Hungary 3 MTA-SE Tumor Progression Research Group, Budapest, Hungary Correspondence to: Tamás Barbai, email: // Keywords : melanoma metastasis, microenvironment, CCL8, miR146a Received : February 19, 2015 Accepted : July 16, 2015 Published : July 31, 2015 Abstract We have attempted to characterize the changes occurring on the host side during the progression of human melanoma. To investigate the role of tumor microenvironment, we set up such an animal model, which was able to isolate the host related factors playing central role in metastasis formation. One of these ’factors’, CCL12, was consequently selected and its behavior was examined alongside its human homologue (CCL8). In our animal model, metastasis forming primary melanoma in the host exhibited increased level of CCL12 mRNA expression. In clinical samples, when examining the tumor and the host together, the cumulative (tumor and host) CCL8 expression was lower in the group in which human primary melanoma formed lung metastasis compared to non-metastatic primary tumors. We could not detect significant difference in CCL8 receptor (CCR1) expression between the two groups. Increased migration of the examined tumor cell lines was observed when CCL8 was applied as a chemoattractant. The tumor cells and their interactions can be influenced the expression of CCL8 by dermal fibroblasts, as a significant change in the metastatic microenvironment. Furthermore, we examined changes in miRNA profile resulted by CCL8 and miR146a appears to be a promising prognostic marker for following this process.
Barbai et al. (Fri,) studied this question.